Content

• Pharmacy Retail (India) — Sector Analysis (With Retail Pharmacy + Distribution Adjacencies)
• A. Industry Overview & Market Landscape
• 1) What The “Pharmacy Retail” Ecosystem Looks Like (As Evidenced By Company Disclosures)
• 2) Market Size And Growth (Only Where Explicitly Quantified)
• 3) Market Structure & Segmentation (Observable In The Two-Company Sample)
• 4) Geographic Distribution And Regional Dynamics
• 5) Market Maturity And Lifecycle
• B. Financial & Economic Profile
• 1) Sector “Two-Layer” Economics: Retail Vs Distribution
• 2) Growth Trajectory And Momentum
• 3) Profitability Levels: Margins, Ranges, And What Drives Them
• 4) Return Profiles (Roce/Roe) And What They Signal
• 5) Working Capital And Cash Conversion: A Major Differentiator
• C. Competitive Structure & Dynamics
• 1) Market Concentration And Scale Signals
• 2) Differentiation Strategies And Moats (Observed)
• 3) Competitive Intensity And Substitutes (As Discussed)
• 4) Consolidation And M&A
• D. Operational Characteristics
• 1) Retail Operating Model Benchmarks (Store Network Economics)
• 2) Retail Inventory And Warehouse “Sweating” Logic
• 3) Omni-Channel Operating Kpis (Retail)
• 4) Diagnostics As An Adjacency (Retail-Linked Services)
• 5) Distribution Operating Model Benchmarks
• E. Growth Dynamics & Drivers
• 1) Retail Growth Drivers (As Stated And Quantified)
• 2) Distribution Growth Drivers (As Stated And Quantified)
• F. Risk Landscape
• 1) Regulatory And Policy Risks
• 2) Competitive And Disruption Risks
• 3) Execution Risks
• 4) Financial Risks
• G. Capital Allocation & Investor Returns
• 1) Capex Intensity And Expansion Spend
• 2) M&A And Consolidation Capital Allocation (Distribution)
• 3) Cash Generation And Ocf Focus
• H. Future Outlook & Projections (Only What Is Explicitly Supported)
• 1) Retail (Medplus) Outlook Statements
• 2) Distribution (Entero) Outlook And Reiterated Guidance
• 3) Structural Themes Likely To Shape The Next Phase (Implied By Strategies)
• I. Company-By-Company Profiles
• Medplus Health Services Limited (Nse: Medplus)
• Business Description And Positioning
• Scale And Network Metrics
• Financial Performance (Q3 Fy26 And Trends)
• Segment Performance (Q3 Fy26)
• Unit Economics And Cohort Dynamics
• Store Rollout And Footprint Strategy
• Private Label Strategy And Economics
• Omni-Channel And Customer Metrics
• Working Capital, Cash, And Accounting Notes
• Management Outlook / Guidance (As Stated)
• Entero Healthcare Solutions Limited (Nse: Entero)
• Business Description And Positioning
• Scale And Footprint
• Financial Performance (Q3 Fy26)
• 9m Fy26 Performance
• Working Capital And Cash Flow
• Capital Structure
• Acquisition And Medtech Strategy
• Management Guidance / Outlook
• Cross-Company Sector Implications (What These Two Windows Collectively Indicate)